In breast cancer, THP-1 treated with CM from MCF-7 or MDA-MB 231 cells results in the differentiation of THP-1 cells toward macrophages and increases the mRNA expression of M2-type macrophage markers, including CD163 and IL-10 [35]. The gene discussed is IL10; the disease is breast carcinoma.